LobbyingAlphyn Biologics lobbying by quarter
Alphyn Biologics's latest lobbying report covers Q2 2026, at under $5,000. The four quarters Q4 2025–Q3 2026 total $30K. Its first report covers Q3 2025; the issues it reports most are Medical/Disease Research/Clinical Labs.
Alphyn Biologics
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $30K
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q3 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2025 | $0 | 1 |
| Q4 2025 | $30K | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medical research and clinical labs$30K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Health & Human Services, Dept of (HHS)1 reports
- SENATE1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Squire Patton Boggs | $30K | 4 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| THOMAS S ANDREWS | 2009-2013:SA/LC and Sr SA, Rep. John Boehner; 2013-2015:SA to Speaker John Boehner; 2015-2018: Dir of Member Services, Speaker Paul Ryan; 2018- 2021: SA to President for Leg Affairs, White House | Q4 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/10for Q2 | Squire Patton Boggs | Under $5,000 |
| 04/14for Q1 | Squire Patton Boggs | Under $5,000 |
| 01/13for Q4 2025 | Squire Patton Boggs | $30K |
| 25/10/18for Q3 2025 | Squire Patton Boggs | Under $5,000 |
| 25/10/16for Q3 2025 | Squire Patton Boggs | Under $5,000 |